Theravance Biopharma, Inc. (TBPH)

USD 9.71

(-2.51%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 381.99 Million 607.4 Million 374.81 Million 469.05 Million 408.82 Million 560.23 Million
Total Current Assets 133.54 Million 353.46 Million 249.87 Million 393.34 Million 338.48 Million 532.82 Million
Cash And Short Term Investments 102.42 Million 327.48 Million 173.46 Million 292.94 Million 280.83 Million 505.27 Million
Cash and Cash Equivalents 39.54 Million 298.17 Million 89.95 Million 81.46 Million 58.06 Million 378.02 Million
Short Term Investments 62.88 Million 29.31 Million 83.5 Million 211.47 Million 222.76 Million 127.25 Million
Net Receivables 17.47 Million 16.78 Million 57.59 Million 69.66 Million 50.57 Million 10.05 Million
Inventory 1.00 1.51 Million 10.24 Million 20.37 Million 1.00 1.00
Other Current Assets 13.64 Million 7.68 Million 8.56 Million 10.35 Million 7.08 Million 17.49 Million
Total Non-Current Assets 248.45 Million 253.93 Million 124.94 Million 75.71 Million 70.33 Million 27.41 Million
Net PPE 45.35 Million 52 Million 53.34 Million 59.68 Million 59.24 Million 13.17 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 836 Thousand 836 Thousand 67.53 Million 12.75 Million 4.98 Million 11.86 Million
Tax Assets - - - - - -
Other Non Current Assets 202.26 Million 201.09 Million 4.06 Million 3.28 Million 6.1 Million 2.36 Million
Other Assets - - - - - -
Total Liabilities 169 Million 165.6 Million 713.39 Million 772.8 Million 632.66 Million 611.82 Million
Total Current Liabilities 24.76 Million 28.71 Million 58.58 Million 123.57 Million 111.7 Million 98.55 Million
Account Payables 1.52 Million 1.55 Million 3.09 Million 6.77 Million 4.75 Million 9.02 Million
Tax Payables - - - - - -
Short Term Debt 3.92 Million 28.71 Million 17.44 Million 29.2 Million 17.61 Million -
Deferred Revenue -5.44 Million 24 Thousand 98 Thousand 11.52 Million 31.57 Million 43.4 Million
Other Current Liabilities 24.76 Million -1.57 Million 37.94 Million 76.07 Million 57.75 Million 46.12 Million
Total Non Current Liabilities 144.23 Million 136.88 Million 654.8 Million 649.23 Million 520.96 Million 513.27 Million
Long-Term Debt 45.23 Million 45.4 Million 652.07 Million 647.05 Million 492.91 Million 454.35 Million
Deferred Revenue Non Current - 192 Thousand 310 Thousand 348 Thousand 6.76 Million 26.17 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 28.56 Million 27.09 Million 2.73 Million 2.18 Million 28.04 Million 58.91 Million
Other Liabilities - - - - - -
Total Equity 212.99 Million 441.8 Million -338.57 Million -303.75 Million -223.84 Million -51.58 Million
Stock Holders Equity 212.99 Million 441.8 Million -338.57 Million -303.75 Million -223.84 Million -51.58 Million
Common Stock - 1000.00 1000.00 1000.00 1000.00 1000.00
Retained Earnings -909.1 Million -853.91 Million -1.72 Billion -1.52 Billion -1.24 Billion -1.01 Billion
Accumulated other comprehensive income -65 Thousand -15 Thousand - 47 Thousand 145 Thousand -166 Thousand
Common Stock Equity 212.99 Million 441.8 Million -338.57 Million -303.75 Million -223.84 Million -51.58 Million
Capital Lease Obligation 45.23 Million 74.12 Million 52.68 Million 47.22 Million 47.72 Million -
Total Investments 836 Thousand 29.31 Million 151.04 Million 224.22 Million 227.75 Million 139.12 Million
Total Debt 45.23 Million 74.12 Million 652.07 Million 647.05 Million 492.91 Million 454.35 Million
Net Debt 5.69 Million -224.05 Million 562.11 Million 565.58 Million 434.85 Million 76.33 Million

Balance Sheet Charts